common glp-1 agonists - What is it? What Are GLP-1 Agonists For

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

Turmeric Extract - Supports Antioxidant Activity*

Demand for these drugs has increased rapidly in recent years, as indications have expanded, but they remain expensive

Here, the authors review the physiological roles of GLP-1, the potential renoprotective mechanisms of incretin-based therapies and the available renal outcome data from clinical trials.